Status: Finalised First registered on: 31/03/2015
Last updated on: 23/10/2018
1. Study identification
EU PAS Register NumberEUPAS9142
Official titleCharacterising patients and examining real-life outcomes for UK patients with COPD initiating on or changing to Fostair
Study title acronymREACH II
Study typeObservational study
Brief description of the studyTwo-stage historical cohort study to evaluate, in a comparative effectiveness study, whether Fostair pMDI is non-inferior, in terms of COPD exacerbation prevention, to other fixed dose combination (FDC) inhaled corticosteroid (ICS) / long-acting beta agonist (LABA) COPD therapies.
Was this study requested by a regulator?No
Is the study required by a Risk Management Plan (RMP)? Not applicable
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicable
2. Research centres and Investigator details
Coordinating study entity
Centre to which the investigator belongsOPRI Pte Ltd
Department/Research groupObservational and Pragmatic Research Institute Pte Ltd
Organisation/affiliationOPRI Pte Ltd
Website/Homepagewww.opri.sg
Details of (Primary) lead investigator
Title Professor
Last name Price
First name David
Is this study being carried out with the collaboration of a research network?
No
Other centres where this study is being conducted
Not applicable (single centre)

Countries in which this study is being conducted
National study

United Kingdom
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed10/02/201510/02/2015
Start date of data collection07/04/201507/04/2015
Start date of data analysis20/04/201520/04/2015
Date of interim report, if expected01/09/201701/09/2017
Date of final study report11/09/201505/09/2017
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companiesChiesi Ltd100
Charities
Government body
Research councils
EU funding scheme
5. Contact details for enquiries
Scientific Enquiries
Title Dr
Last name Wan Yau Ming
First name Simon
Address line 116 Raffles Quay
Address line 2#33-03 
Address line 3Hong Leong Building 
CitySingapore 
Postcode048581 
CountrySingapore
Phone number (incl. country code)441223967829 
Alternative phone number 
Fax number (incl. country code) 
Email address simon@opri.sg
Public Enquiries
Title Dr 
Last name Wan Yau Ming 
First name Simon 
Address line 116 Raffles Quay 
Address line 2#33-03 
Address line 3Hong Leong Building 
CitySingapore 
Postcode048581 
CountrySingapore 
Phone number (incl. country code)441223967829 
Alternative phone number 
Fax number (incl. country code) 
Email address simon@opri.sg 
Top